Aske Merrild
amerrild.bsky.social
Aske Merrild
@amerrild.bsky.social
Reposted by Aske Merrild
Biosynthesis, Structure, and Antibiotic Properties of Gelatinamin A, a Triculamin-like Lasso Peptide https://www.biorxiv.org/content/10.64898/2025.12.02.691826v1
December 6, 2025 at 2:45 AM
Thanks for a great colab Marc!
February 21, 2025 at 5:27 PM
>80 grams of engineered lasso peptide from 20 L E. Coli fermentation broth. This and more amazing results from Lassogen in preprint.
Overcoming Immune Checkpoint Inhibitor Resistance via Potent and Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides https://www.biorxiv.org/content/10.1101/2025.01.28.635346v1
February 2, 2025 at 11:42 PM
Reposted by Aske Merrild
We are excited to see our review published! In it, we explore the diversity of enzymatic strategies for installing aromatic side chain cross-links in RiPPs. If you like interesting chemistry and new enzyme reactions, be sure to check it out!
January 16, 2025 at 6:30 PM
Reposted by Aske Merrild
I’m not entirely sure how these starter packs work…
but I’ve created one for microbial natural products - hopefully it helps us connect! go.bsky.app/72NeGsT
October 19, 2024 at 8:37 PM
Reposted by Aske Merrild
A Christmas present to all of the lasso peptide connoisseurs out there. The next chapter in our work is on triculamin is ready on bioRxiv. Great work by two incredibly talented graduate students @amerrild.bsky.social and @tizianasvenningsen.bsky.social.
www.biorxiv.org/content/10.1...
Convergent Evolution of the Antimycobacterial Lasso Peptide Triculamin
Triculamin is a ribosomally synthesized and post-translationally modified peptide (RiPP) lasso peptide with potent antimycobacterial activity, produced by an unusual, non-canonical biosynthetic gene c...
www.biorxiv.org
December 22, 2024 at 9:52 AM